Gilead Says Understand the Urgent Need for a Covid-19 Treatment and the Resulting Interest in Data on Our Investigational Antiviral Drug Remdesivir; Says Anecdotal Reports Do Not Provide Statistical Power Necessary to Determine Safety, Efficacy Profile of Remdesivir as Treatment for Covid-19